Plasma clearance
Tóm tắt
Plasma (total, systemic…) clearance is determined by all the individual metabolizing/eliminating organ clearances and involves mainly liver and kidney clearances. Plasma clearance (a volume per time, i.e. a flow) expresses the overall ability of the body to eliminate a drug by scaling the drug elimination rate (amount per time) by the corresponding plasma concentration level. The interpretation of plasma clearance and inter‐species comparisons are made easier by computing the overall body extraction ratio (from 0 to 1), which is the ratio of the body clearance divided by cardiac output. Plasma clearance is the most important pharmacokinetic parameter because it is the only one which controls the overall drug exposure (for a given bioavailability) and it is the parameter which allows computation of the dosage required to maintain an average steady‐state plasma concentration.
Từ khóa
Tài liệu tham khảo
Baggot J.D., 1977, Principles of Drug Disposition in Domestic Animals: the Basis of Veterinary Clinical Pharmacology
Baggot J.D., 1973, Species differences in plasma protein binding of morphine and codeine, American Journal of Veterinary Research, 34, 571
Chiou W.L., 1982, The physiological significance of total body clearance in pharmacokinetic studies, Journal of Clinical and Hospital Pharmacy, 7, 25
Combie J.D., 1983, Pharmacokinetics and protein binding of morphine in horses, American Journal of Veterinary Research, 44, 870
Hinderling P.H., 1997, Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics, Pharmacological Reviews, 49, 279
Marroum P.J., 1994, Pharmacokinetics and pharmacodynamics of acepromazine in horses, American Journal of Veterinary Research, 55, 1428, 10.2460/ajvr.1994.55.10.1428
Riviere J.E., 1999, Comparative Pharmacokinetics. Principles, Techniques and Applications
Rowland M., 1995, Clinical Pharmacokinetics. Concepts and Applications
Schulz M., 1997, Therapeutic and toxic blood concentrations of more than 500 drugs, Pharmazie, 52, 895
Toutain P.L., 2002, 14th International Conference of Racing Analysts and Veterinarians, 19
Toutain P.L., 2000, Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach, Journal of Pharmacology and Experimental Therapeutics, 292, 1087
Wilkinson G.R., 1987, Clearance approaches in pharmacology, Pharmacological Reviews, 39, 1